AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFS.
Saved in:
| Title: | AI-Powered Lesion-Level Tumor Growth Inhibition Modeling Improves Model Stability and Prognostic Association With PFS. |
|---|---|
| Authors: | Liu A; Pfizer Inc, New York, New York, USA., Duan C; Pfizer Inc, Cambridge, Massachusetts, USA., Maresca K; Pfizer Inc, Cambridge, Massachusetts, USA., Pithavala YK; Senior Clinical Pharmacology Consultant, Assistant Clinical Professor, UCSD Skaggs School of Pharmacy, San Diego, California, USA., Lu JT; Vysioneer Inc, Cambridge, Massachusetts, USA., Guo CC; Pfizer Inc, La Jolla, California, USA., Hibma JE; Pfizer Inc, La Jolla, California, USA. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2026 Jun; Vol. 15 (6), pp. e70279. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2163-8306 |
|---|---|
| DOI: | 10.1002/psp4.70279 |
